secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0001628280-25-016794
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Esperion CCO Eric Warren to depart effective April 18, 2025
-----------------------------------------------------------

- Eric Warren stepping down as Chief Commercial Officer, effective April 18, 2025.
- Departure not the result of any disagreement with the Company on operations, policies, or practices.
- No successor or interim CCO announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000162828025016794/0001628280-25-016794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000162828025016794/espr-20250404.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-016794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer